南模生物：2025年年度业绩预告

Core Viewpoint - Nanmo Biological announced an expected annual revenue of between 400 million to 430 million yuan for 2025, with a net profit attributable to the parent company expected to be between 24 million to 34 million yuan [1] Financial Projections - The company anticipates achieving an operating income ranging from 400 million yuan to 430 million yuan in 2025 [1] - The projected net profit for the parent company is estimated to be between 24 million yuan and 34 million yuan [1]